Mattern Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
10,188
+591
+6% +$604K 1.43% 12
2026
Q1
$8.83M Sell
9,597
-147
-2% -$149K 1.06% 48
2025
Q4
$10.5M Sell
9,744
-1,169
-11% -$1.12M 1.24% 21
2025
Q3
$8.33M Buy
10,913
+3,673
+51% +$2.73M 0.98% 52
2025
Q2
$5.64M Buy
7,240
+728
+11% +$566K 0.68% 77
2025
Q1
$5.38M Buy
6,512
+5,705
+707% +$4.75M 0.68% 75
2024
Q4
$623K Buy
807
+522
+183% +$432K 0.08% 114
2024
Q3
$252K Hold
285
0.03% 149
2024
Q2
$258K Hold
285
0.04% 148
2024
Q1
$222K Buy
+285
New +$203K 0.03% 156

Other funds holding LLY

Mattern Capital Management's LLY Position: Q2 2026 in Review

Mattern Capital Management increased its Eli Lilly (LLY) stake by 6.2% in Q2 2026, buying an estimated $604K and bringing the position to 10,188 shares worth $12.2M. The position accounts for 1.43% of the portfolio, ranked #12.

Mattern Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,587 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mattern Capital Management held 10,188 shares of Eli Lilly worth $12.2M as of Q2 2026.
  • Mattern Capital Management bought 591 Eli Lilly shares in Q2 2026, an estimated $604K.
  • Eli Lilly made up 1.43% of Mattern Capital Management's portfolio in Q2 2026, its #12 holding.
  • Mattern Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,587 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mattern Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.